Showing results (241-250 of 435) with videos related to

Sort By:
Pageof 44
Annals of Surgery|July 19, 2023
Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant TherapyMichael G White, Ashish Damania, Jumanah Alshenaifi, et al.
Diseases of the Colon and Rectum|February 23, 2022
Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics ProgramY Nancy You, Julie B Moskowitz, George J Chang, et al.
Cancer|September 22, 2024
The prognostic impact of tumor deposits in colorectal cancer: More than just N1cNeal Bhutiani, Oliver Peacock, Abhineet Uppal, et al.
Cancer|July 23, 2013
Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastasesAntoine Brouquet, Giuseppe Zimmitti, Scott Kopetz, et al.
American Journal of Cancer Research|January 10, 2018
Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatmentKrittiya Korphaisarn, Chao-Kai Chou, Wei-Ya Xia, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
JAMA Network Open|May 24, 2022
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic ReviewChan Shen, Daniel Tannenbaum, Robert Horn, et al.
British Journal of Cancer|July 24, 2024
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancerNeil H Segal, Jeanne Tie, Scott Kopetz, et al.
Advanced Healthcare Materials|October 14, 2025
Decellularized Extracellular Matrix Scaffolds to Engineer the Dormant Landscape of Microscopic Colorectal Cancer Liver MetastasisSabrina N VandenHeuvel, Lucia L Nash, Abigail J Clevenger, et al.
British Journal of Cancer|September 3, 2024
Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumorsSaikat Chowdhury, Joanne Xiu, Jennifer R Ribeiro, et al.
Pageof 44